You are here: Home » Markets » News
Business Standard

Sensex, Nifty end higher as banks return to gains after early sell-off

Gains among banking stocks have helped the main Nifty index rise over 19% so far this month

Topics
stock market | Sensex | Nifty

Reuters  |  Bengaluru 

banking stocks
The NSE Nifty 50 index and the benchmark S&P BSE Sensex ended about 0.2% higher at 12,719.95 and 43,443

Indian shares ended higher in a choppy trading session on Friday as banking and reversed early losses, with the main indexes recording gains for a second week in a row. The NSE 50 index and the benchmark S&P ended about 0.2% higher at 12,719.95 and 43,443, respectively. The indexes, which posted weekly gains of over 3% each, had fallen as much as 0.6% during the session.

The banking index closed 0.66% higher during the session and rose for four of five days this week, advancing 19% so far this month.

"Some of the private-sector banks are doing very well in terms of capital adequacy ratios and risk management compared to the industry average and they have seen large gains in the current rally," said Saurabh Jain, assistant vice president at SMC Global Securities Ltd.

Gains among have helped the main index rise over 19% so far this month.

India's top lender State Bank of India firmed 1.5%, while its private-sector peers Axis Bank and ICICI Bank advanced about 1.8% each. The Nifty realty rose about 1.3% after the government announced a new set of stimulus measures, including additional funding for real estate developers and contractors.

Oil-to-telecoms conglomerate and India's most valuable company Reliance Industries gained about 1% after recovering from a 5% drop in the last two sessions.

Automaker Eicher Motors firmed 7.4% and was the top gainer among Nifty stocks after the company reported a better-than-expected profit in the July-September quarter on Thursday.

Rival automaker Tata Motors was the session's top loser and fell about 3.3%.

Meanwhile, MSCI's all-country equity index slipped 0.1% as rising coronavirus infections in the United States and Europe offset optimism from a potential vaccine.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, November 13 2020. 16:26 IST
RECOMMENDED FOR YOU
.